The targeting ability of fluorescent quantum dots to the folate receptor rich tumors

Area of Science:

• Nanotechnology in medicine
• Biomedical engineering
• Quantum dot applications

Background:

• Quantum dots (QDs) offer advanced capabilities for cancer theranostics due to their brightness and surface modifiability.
• Targeted QDs are promising for fluorescence-guided surgery and photodynamic therapy.
• Existing studies often use 2D models, limiting in vivo relevance; this study utilizes a 3D tumor model.

Purpose of the Study:

• To evaluate the targeting efficacy of folic acid-conjugated quantum dots (QD-FA) in a 3D tumor spheroid model.
• To assess the specificity of QD-FA for folate receptor-positive cancer cells.
• To compare the uptake and distribution of targeted versus non-targeted QDs within a tumor microenvironment.

Main Methods:

• Synthesis and spectroscopic characterization of core/multilayer shell CdSe/CdS/ZnS QDs conjugated with folic acid (FA).
• Evaluation of QD cytotoxicity using MTT assays on KB and A549 cell lines.
• Assessment of cellular uptake and distribution via epifluorescence microscopy in 2D cell cultures and 3D KB spheroids.

Main Results:

• QD-FA demonstrated specific targeting of folate receptor-positive KB cells.
• Enhanced uptake of QD-FA was observed in the 3D tumor spheroid model compared to non-targeted QDs.
• Penetration depth for both QD types in spheroids did not exceed 100 μm.

Conclusions:

• Folic acid-conjugated QDs effectively target tumor spheroids, validating the folate receptor alpha (FRα) as a key target.
• The study highlights the importance of 3D models for assessing theranostic agent efficacy.
• Future strategies may involve dual targeting with agents like FA and cyclic RGD to further enhance QD targeting capabilities.